Antibiotic shot for severe infections vs. IV method
Part of Infections clinical trials.
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a severe infection that needs the antibiotic piperacillin/tazobactam by continuous IV drip, such as severe pneumonia or fever due to low white blood cells.
- You are not allergic to penicillin, cephalosporins, or similar antibiotics.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use highly effective birth control.
- You are admitted to a hospital ward that is part of this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways of giving the antibiotic ceftazidime/avibactam (as a continuous drip or as intermittent shots) to patients in the intensive care unit with severe infections. The goal is to see which method works better or is safer for critically ill patients.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This study looks at whether giving two antibiotics together is better for people hospitalized with severe pneumonia. It may help doctors choose the most effective treatment.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
Hear when a new Bacteria Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.